IL17A and arthritic joint disease: The mice that did not receive anti-IFN-γ antibody (Rat IgG and Control groups) did not develop arthritis by day 21 to 23 and consequently the levels of IFN-γ, IL-4, and IL-17 in the paws remained significantly lower than the mice that received anti-IFN-γ.